A 35-year-old cisgender woman presents with a 5-day history of severe vaginal itching and pain during urination. She denies fevers, chills, or pelvic pain. She is sexually active with one cisgender man, and they consistently use condoms. She has been diagnosed with vulvovaginal candidiasis four times previously in the past 12 months, for which she has received multiple courses of oral fluconazole (150 mg single dose). On physical examination, vulvar erythema and thick white vaginal discharge are visualized. Budding yeasts are seen on a Gram’s stain of a wet mount on a sample taken from the vagina and a vaginal discharge fungal culture subsequently grows Candida glabrata.
Although the optimal therapy for non-albicans vulvovaginal candidiasis remains unknown, which one of the following should be considered as an initial option to treat Candida glabrata vulvovaginal infection in this woman?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
March 25th, 2022
March 25th, 2022
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME+MOC
4
Give Feedback
Complete survey
5